Effect of Hejie decoction on T cell immune state of chronic hepatitis B patients

Table 2 T lymphocyte subsets before and after treatment (mean ± SD)

		n	CD3 (%)	CD4 (%)	CD8 (%)	CD4/CD8
Normal		10	67.80 ± 8.65	39.07 ± 8.50	30.55 ± 5.52	1.62 ± 0.46
Treatment	Pre-T	40	65.97 ± 8.45	34.76 ± 4.82b	34.08 ± 4.36b	1.04 ± 0.32
	Post-T	40	67.01 ± 9.75	37.39 ± 8.97a	32.35 ± 5.52a	1.20 ± 0.30a
Control	Pre-T	25	65.70 ± 9.11	35.02 ± 5.21b	34.87 ± 6.78b	1.02 ± 0.29
	Post-T	25	66.01 ± 9.75	35.88 ± 8.97	34.15 ± 5.52	1.09 ± 0.39

n: Number; normal: Normal group; treatment: Treatment group; control: Control group; Pre-T: Before treatment; Post-T: After treatment;

^aP < 0.05, vs before treatment in the same group,

^bP < 0.01, vs control.